Purchase Order 75F40123P00024
Award Date 1/18/23
Potential Completion Date 1/16/24
Potential Value $30K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Milpitas, CA 95035, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $44,520 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business located in Fremont, California. The contract is for whole exome sequencing (WES) of 95 genomic DNA samples derived from acute liver failure patients. This work is being performed under a total small business set-aside. Seqmatic, LLC is a provider of advanced genomics and bioinformatics services, and has secured...
- The U.S. Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke awarded a firm fixed-price delivery order contract worth $23,487.91 to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis solutions, to provide whole exome sequencing (WES) kits and NextSeq2000 reagents. The purpose is to perform WES and detect pathogenic variants in sporadic pituitary adenomas. This award has no set-aside...
- This firm-fixed price purchase order for $600,000 was awarded by the National Institute on Aging, a component of the National Institutes of Health within the Department of Health and Human Services, to Psomagen, Inc. for whole genome sequencing services. Under the terms of the contract, Psomagen will sequence 1,000 human samples to 30x coverage using Illumina sequencing technologies and deliver raw sequencing data files within 4-6 weeks. The work will be performed in Potomac, Maryland over a one...
- This firm fixed-price purchase order in the amount of $72,600.00 was awarded by the National Institute of Child Health and Human Development (NICHD) to Novogene Corporation Inc., a minority-owned small business, for whole exome sequencing services. The award is for an ongoing project focused on identifying new genetic causes of adrenal and pituitary tumors and analyzing the effects of such genetic alterations. The effort involves DNA library preparation, sequencing, and customized bioinformatics...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $240,622 firm fixed price purchase order to Baylor College of Medicine. The contract calls for whole genome sequencing of 200 samples to support NIAID's research efforts. Specifically, the contractor will perform clinical whole genome sequencing, sample processing, and data analysis on samples provided by NIAID. The sequencing must meet CLIA and CAP...
- The National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), awarded a Firm Fixed Price Purchase Order contract to Psomagen Inc., a subsidiary of Macrogen, Inc., for $10,272.00. The contract is for the delivery of 48 units of Whole Exome Sequencing services, with a completion date of February 29, 2020. This contract was not set aside for any specific business size or type. Psomagen Inc. is a multiomics contract laboratory service and...
- Genedx, LLC, a division of Opko Health, Inc., has been awarded a $25,000 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to provide exome and genome sequencing with optional mitochondrial testing for various patients. The contract has a period of performance of just over one year, running from September 2023 through August 2024. Genedx will perform the sequencing and testing services at its laboratory location in Montgomery Village,...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $345,333 firm fixed price purchase order to Genewiz, LLC for whole genome sequencing services using 90 human induced pluripotent stem cell samples. The solicitation sought these sequencing services to be performed within 45 days of sample receipt in September 2020. Genewiz will conduct the work at its facility in South Plainfield, New Jersey as the incumbent...
- The National Cancer Institute (NCI) awarded a $2,556,500 firm-fixed-price delivery order contract to The Johns Hopkins University to provide high-throughput genotyping and DNA sequencing services for studying the genetic contributions to human health and disease. The contract will fund whole exome sequencing of saliva samples and a whole genome sequencing upgrade. This delivery order is part of a larger indefinite delivery/indefinite quantity (IDIQ) contract that allows The Johns Hopkins...
- The National Institutes of Health National Heart Lung and Blood Institute awarded a $484,000 purchase order contract to Psomagen Inc., a subsidiary of Macrogen, Inc., to provide Whole Genome Sequencing on DNA. The contract has a period of performance starting on May 17, 2022 through May 16, 2023 and utilizes a firm fixed price pricing structure. The place of performance will be Potomac, Maryland. Psomagen Inc. will perform whole genome sequencing services on DNA samples for the National Heart...
WHOLE EXOME SEQUENCING OF GENOMIC DNA SAMPLES
Posted 1/18/23
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.8k | 1/18/23 |